Low desire is one of the most common concerns I hear from women, especially during perimenopause and menopause. But low libido is not simply a hormone problem, and it is not a personal failure. Desire is shaped by hormones, stress, nervous system regulation, relationship dynamics, sleep, mental health, and overall wellbeing.

In this article, Dr. Evelin Dacker explores the complex roots of low desire in women and discusses evidence-based options that may help support arousal and sexual connection, including PT-141 (Bremelanotide), Addyi (Flibanserin), cannabis, and a more holistic approach to female sexual health and vitality.

PCOS has been officially renamed PMOS: Polyendocrine Metabolic Ovarian Syndrome. Dr. Evelin Dacker explains the HPA axis dysfunction driving the condition, the cardiovascular and inflammatory risks most physicians miss, and the treatment landscape beyond metformin and birth control.